{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:59:50Z","timestamp":1777694390310,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.hrthm.2006.07.017","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T18:53:07Z","timestamp":1153507987000},"page":"1339-1345","source":"Crossref","is-referenced-by-count":28,"title":["Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block"],"prefix":"10.1016","volume":"3","author":[{"given":"Avram","family":"Oros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G.A.","family":"Volders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jet D.M.","family":"Beekman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"van der Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2006.07.017_bib1","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.155.5.469","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2006.07.017_bib2","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1161\/01.STR.32.3.803","article-title":"Atrial fibrillation and stroke: concepts and controversies","volume":"32","author":"Hart","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.hrthm.2006.07.017_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.hrthm.2006.07.017_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nrd1876","article-title":"Drug therapy for atrial fibrillation: where do we go from here?","volume":"4","author":"Page","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.hrthm.2006.07.017_bib5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1046\/j.1540-8167.2004.04569.x","article-title":"Atrial-specific drugs: the way to treat atrial fibrillation?","volume":"15","author":"Vos","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib6","first-page":"BR221","article-title":"Atrial-selective antiarrhythmic actions of novel Ikur vs","volume":"10","author":"Knobloch","year":"2004","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.hrthm.2006.07.017_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00210-004-0957-y","article-title":"Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels","volume":"370","author":"Gogelein","year":"2004","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/01.RES.73.6.1061","article-title":"Sustained depolarization-induced outward current in human atrial myocytes","volume":"73","author":"Wang","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2006.07.017_bib9","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1161\/01.CIR.0000145155.60288.71","article-title":"Role of IKur in controlling action potential shape and contractility in the human atrium: influence of chronic atrial fibrillation","volume":"110","author":"Wettwer","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib10","first-page":"H1393","article-title":"A direct negative inotropic effect of acetylcholine on rat ventricular myocytes","volume":"265","author":"McMorn","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1177\/002215540104901004","article-title":"Distribution of the muscarinic K+ channel proteins Kir3.1 and Kir3.4 in the ventricle, atrium, and sinoatrial node of heart","volume":"49","author":"Dobrzynski","year":"2001","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.hrthm.2006.07.017_bib12","doi-asserted-by":"crossref","first-page":"H667","DOI":"10.1152\/ajpheart.00180.2005","article-title":"Diverse phenotypes of outward currents in cells that have survived in the 5-day-infarcted heart","volume":"289","author":"Dun","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0008-6363(03)00543-1","article-title":"Atrial effects of the novel K(+)-channel-blocker AVE0118 in anesthetized pigs","volume":"60","author":"Wirth","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2006.07.017_bib14","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1161\/01.CIR.0000143050.22291.2E","article-title":"\u201cEarly\u201d class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat","volume":"110","author":"Blaauw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tips.2003.10.002","article-title":"Assessing predictors of drug-induced torsade de pointes","volume":"24","author":"Belardinelli","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.hrthm.2006.07.017_bib16","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/jpet.103.052753","article-title":"Electrophysiological safety of sertindole in dogs with normal and remodeled hearts","volume":"307","author":"Thomsen","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl III","key":"10.1016\/j.hrthm.2006.07.017_bib17","first-page":"193","article-title":"AVE0118, an Ito and IKur blocker, suppresses VT\/VF in an experimental model of the Brugada syndrome","volume":"110","author":"Fish","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib18","first-page":"99","article-title":"AVE0118, a novel transient outward current antagonist, protects against ischemically induced ventricular fibrillation","volume":"110","author":"Billman","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0008-6363(03)00430-9","article-title":"Asynchronous development of electrical remodeling and cardiac hypertrophy in the complete AV block dog","volume":"59","author":"Schoenmakers","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2006.07.017_bib20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0014-2999(00)00943-2","article-title":"Azimilide and dofetilide produce similar electrophysiological and proarrhythmic effects in a canine model of torsade de pointes arrhythmias","volume":"412","author":"Van Opstal","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib21","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.91.3.864","article-title":"Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block","volume":"91","author":"Vos","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0160-5402(89)90015-6","article-title":"An improved method to correct the QT interval of the electrocardiogram for changes in heart rate","volume":"22","author":"Van de Water","year":"1989","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.hrthm.2006.07.017_bib23","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.0000145162.64183.C8","article-title":"Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs","volume":"110","author":"Thomsen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib24","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1016\/j.jacc.2004.09.021","article-title":"A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation","volume":"44","author":"Roy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib25","first-page":"II-329","article-title":"Facilitation of DC cardioversion of atrial fibrillation\/flutter and reduced immediate relapse with intravenous AZD7009","volume":"112","author":"Van Gelder","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib26","first-page":"168","article-title":"Effects of the novel atrial drug AVE0118 on action potentials in isolated atria","volume":"1","author":"Goegelein","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2006.07.017_bib27","first-page":"1525","article-title":"Mode of positive inotropic action of the novel K+-channel blocker AVE0118","volume":"110","author":"Schotten","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2006.07.017_bib28","first-page":"93","article-title":"Restoration of atrial contractile force by atrial K-channel blocker AVE0118 in isolated atrial myocardium of patients with chronic atrial fibrillation","volume":"1","author":"Schotten","year":"2004","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2006.07.017_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1253\/circj.66.185","article-title":"Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter","volume":"66","author":"Nagasawa","year":"2002","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2006.07.017_bib30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1540-8167.2004.04354.x","article-title":"Azd7009: a new antiarrhythmic drug with predominant effects on the atria effectively terminates and prevents reinduction of atrial fibrillation and flutter in the sterile pericarditis model","volume":"15","author":"Goldstein","year":"2004","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/sj.bjp.0706203","article-title":"Decreasing the infusion rate reduces the proarrhythmic risk of NS-7: confirming the relevance of short-term variability of repolarisation in predicting drug-induced torsades de pointes","volume":"145","author":"Detre","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib32","first-page":"4","article-title":"Moxifloxacin causes no torsades de pointes despite massive QT intervals","volume":"3","author":"Thomsen","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2006.07.017_bib33","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.hrthm.2005.02.321","article-title":"Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes","volume":"2","author":"Thomsen","year":"2005","journal-title":"Heart Rhythm"},{"issue":"Suppl","key":"10.1016\/j.hrthm.2006.07.017_bib34","first-page":"298A","article-title":"Sarcoplasmic Reticulum Ca2+ release and repolarization lability in myocytes from the dog with chronic atrioventricular block (cAVB)","author":"Antoons","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.hrthm.2006.07.017_bib35","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1540-8167.2005.40720.x","article-title":"Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes","volume":"16","author":"Wu","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hrthm.2006.07.017_bib36","first-page":"395","article-title":"Synergistic class III action of blockade of Ikur\/Ito (AVE 0118) and IKr (dofetilide\/ibutilide) in electrically remodeled atria of the goat","volume":"108","author":"Blaauw","year":"2003","journal-title":"Circulation"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106017929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527106017929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T23:53:18Z","timestamp":1547509998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527106017929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S1547527106017929"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2006.07.017","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}